Lentivirus-Mediated Silencing of Myosin VI Inhibits Proliferation and Cell Cycle Progression in Human Lung Cancer Cells.

作者: Hui Yu , Zhenghong Zhu , Jianhua Chang , Jialei Wang , Xiaoyong Shen

DOI: 10.1111/CBDD.12528

关键词:

摘要: Myosin VI (MYO6) is a unique actin motor, which moves toward the pointed ends of filaments. In this study, we found that MYO6 overexpressed in lung cancer tissues and associated with progression, particularly lymph node metastasis. To investigate its functions cells, generated recombinant lentivirus taking shRNA MYO6. Using two cell lines, A549 95D, Lv-shMYO6 could infect cells high efficiency downregulate on both mRNA protein levels. After knockdown MYO6, proliferation rates were decreased significantly. The colony-formation ability MYO6-silenced was also impaired reduced colony numbers fewer per colony. Flow cytometry showed cycle progression stuck at G0 /G1 phase, especially sub-G1 represents apoptotic cells. Moreover, downregulated phosphorylation ERK1/2. Further experiments using another confirmed above results. These results suggest crucial maintaining growth may serve as potential therapeutic target for treatment.

参考文章(36)
Amber L. Wells, Abel W. Lin, Li-Qiong Chen, Daniel Safer, Shane M. Cain, Tama Hasson, Bridget O. Carragher, Ronald A. Milligan, H. Lee Sweeney, Myosin VI is an actin-based motor that moves backwards Nature. ,vol. 401, pp. 505- 508 ,(1999) , 10.1038/46835
S Sugiura, Actin—myosin interaction Cardiovascular Research. ,vol. 44, pp. 266- 273 ,(1999) , 10.1016/S0008-6363(99)00219-9
Hongju Wu, Joanne E. Nash, Pedro Zamorano, Craig C. Garner, Interaction of SAP97 with Minus-end-directed Actin Motor Myosin VI IMPLICATIONS FOR AMPA RECEPTOR TRAFFICKING Journal of Biological Chemistry. ,vol. 277, pp. 30928- 30934 ,(2002) , 10.1074/JBC.M203735200
Sophie Chheang, Kathleen Brown, Lung cancer staging: clinical and radiologic perspectives. Seminars in Interventional Radiology. ,vol. 30, pp. 099- 113 ,(2013) , 10.1055/S-0033-1342950
Lisa M Bond, David A Tumbarello, John Kendrick-Jones, Folma Buss, Small-molecule inhibitors of myosin proteins. Future Medicinal Chemistry. ,vol. 5, pp. 41- 52 ,(2013) , 10.4155/FMC.12.185
C Puri, M V Chibalina, S D Arden, A J Kruppa, J Kendrick-Jones, F Buss, Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis Oncogene. ,vol. 29, pp. 188- 200 ,(2010) , 10.1038/ONC.2009.328
Sarah M. Heissler, Jayashankar Selvadurai, Lisa M. Bond, Roman Fedorov, John Kendrick-Jones, Folma Buss, Dietmar J. Manstein, Kinetic properties and small-molecule inhibition of human myosin-6 FEBS Letters. ,vol. 586, pp. 3208- 3214 ,(2012) , 10.1016/J.FEBSLET.2012.07.014
Claire L Warner, Abigail Stewart, J Paul Luzio, Karen P Steel, Richard T Libby, John Kendrick‐Jones, Folma Buss, Loss of myosin VI reduces secretion and the size of the Golgi in fibroblasts from Snell’s waltzer mice The EMBO Journal. ,vol. 22, pp. 569- 579 ,(2003) , 10.1093/EMBOJ/CDG055
Thomas A. Dunn, Shenglin Chen, Dennis A. Faith, Jessica L. Hicks, Elizabeth A. Platz, Yidong Chen, Charles M. Ewing, Jurga Sauvageot, William B. Isaacs, Angelo M. De Marzo, Jun Luo, A novel role of myosin VI in human prostate cancer American Journal of Pathology. ,vol. 169, pp. 1843- 1854 ,(2006) , 10.2353/AJPATH.2006.060316
K A Kellerman, K G Miller, An unconventional myosin heavy chain gene from Drosophila melanogaster. Journal of Cell Biology. ,vol. 119, pp. 823- 834 ,(1992) , 10.1083/JCB.119.4.823